Treatment Using Both Voclosporin and Belimumab in Four Patients With Lupus Nephritis.
Cureus
; 15(5): e38848, 2023 May.
Article
em En
| MEDLINE
| ID: mdl-37303434
ABSTRACT
Nearly 50% of patients with systemic lupus erythematosus (SLE) will develop lupus nephritis (LN). Current treatment regimens for LN are suboptimal as the majority of patients fail to achieve complete renal response after several months of treatment and there are high rates of relapse. We report outcomes in four LN patients who were treated with both voclosporin and belimumab. These patients had no serious infections, and we were able to taper glucocorticoids and reduce proteinuria.
Texto completo:
1
Bases de dados:
MEDLINE
Idioma:
En
Revista:
Cureus
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Estados Unidos